In addition, our studies on FANCD2 variants demonstrate an in-depth understanding of how FA signaling is timely in guarding genome stability, which may bring promising biomarkers that are useful for cancer prevention and/or earlier cancer diagnosis. The gene discussed is FANCA; the disease is cancer.